Aasarød K, Ramezanzadehkoldeh M , Shabestari M, Mosti M, Stunes A, Reseland J, Beisvåg V, Eriksen E, Sandvik A, Boyce M, Skallerud B, Syversen U, Fossmark R. The gastrin/CCK2 receptor antagonist netazepide improves bone quality in H+/K+ATPase beta subunit KO mice. J Endocrinol 2016; 230: 251–262.